Clinical Pharmacogenetics Implementation Consortium Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2018 Update

MV Relling, M Schwab, M Whirl‐Carrillo… - Clinical …, 2019 - Wiley Online Library
Thiopurine methyltransferase (TPMT) activity exhibits a monogenic codominant inheritance
and catabolizes thiopurines. TPMT variant alleles are associated with low enzyme activity …

Novel non-calcemic secosteroids that are produced by human epidermal keratinocytes protect against solar radiation

AT Slominski, Z Janjetovic, TK Kim… - The Journal of steroid …, 2015 - Elsevier
CYP11A1 hydroxylates the side chain of vitamin D3 (D3) in a sequential fashion [D3→ 20S
(OH) D3→ 20, 23 (OH) 2 D3→ 17, 20, 23 (OH) 3 D3], in an alternative to the classical …

Novel approaches to glioma drug design and drug screening

SA Patil, A Hosni-Ahmed, TS Jones, R Patil… - Expert Opinion on …, 2013 - Taylor & Francis
Introduction: Gliomas are considered the most malignant form of brain tumors, and ranked
among the most aggressive human cancers. Despite advance standard therapy the …

Melatonin and its metabolites ameliorate ultraviolet B‐induced damage in human epidermal keratinocytes

Z Janjetovic, ZP Nahmias, S Hanna… - Journal of pineal …, 2014 - Wiley Online Library
We investigated the protective effects of melatonin and its metabolites: 6‐hydroxymelatonin
(6‐OHM), N1‐acetyl‐N2‐formyl‐5‐methoxykynuramine (AFMK), N‐acetylserotonin (NAS) …

Pharmacogenetic variants in TPMT alter cellular responses to cisplatin in inner ear cell lines

AP Bhavsar, EP Gunaretnam, Y Li, JS Hasbullah… - PLoS …, 2017 - journals.plos.org
Cisplatin is a highly-effective and widely-used chemotherapeutic agent that causes
ototoxicity in many patients. Pharmacogenomic studies of key genes controlling drug …

Synthesis and in vitro evaluation of novel 1, 2, 3, 4-tetrahydroisoquinoline derivatives as potent antiglioma agents

R Patil, A Hosni-Ahmed, TS Jones… - Anti-Cancer Agents …, 2014 - ingentaconnect.com
Glioblastoma Multiforme (GBM) continues to demand improved chemotherapeutic solutions.
In order to discover novel chemotherapeutic agents for GBM, we identified novel …

急性淋巴细胞白血病硫嘌呤类药物耐药机制的研究进展

方后顺, 李慧, 杨帆, 艾晓杰… - 上海交通大学学报(医学 …, 2016 - xuebao.shsmu.edu.cn
硫嘌呤类药物是急性淋巴细胞白血病(ALL) 治疗缓解期的常用化学治疗药物之一,
其在体内需经代谢转化成具有生物活性的巯基鸟嘌呤核苷酸, 发挥杀死肿瘤细胞的作用 …

[PDF][PDF] Supplemental Material Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for thiopurine dosing based on TPMT and NUDT15 genotypes …

MV Relling, M Schwab, M Whirl-Carrillo… - files.cpicpgx.org
For TPMT, we searched the PubMed database from 1966 to October 2012 for the original
guideline and then Oct 1, 2012 to June 6, 2017 for this guideline update for keywords …

Determining the role of thiopurine metabolism using immunological, molecular biology methods, and metabolic status in patients with inflammatory bowel disease

P Zaļizko - 2022 - dspace.lu.lv
The aim of this Doctoral Thesis was to investigate the interindividual variability of thiopurine
metabolism using immunological, molecular biology methods, and metabolic status in …

[PDF][PDF] Azathioprine indced liver cirrhosis: an unusual side effect

ABS Trabelsi, E Hamami, M Ksiaa, A Souguir… - Open J …, 2013 - academia.edu
In recent years, the hepatotoxic potential of thiopurines, in particular 6-thioguanine (6-TG),
has been discussed in literature. However, cirrhosis was exceptionally reported. We report …